波士顿科学报道 EKOS系统在临床试验中减少了61%的肺栓塞死亡. Boston Scientific reports EKOS system reduces pulmonary embolism deaths by 61% in clinical trial.

波士顿科学院宣布HI- PEITHO临床试验的积极结果显示,EKOS内血管系统在治疗急性肺栓塞时比单独抗凝药更有效. Boston Scientific announced positive results from the HI-PEITHO clinical trial showing the EKOS Endovascular System is more effective than anticoagulation alone for treating acute pulmonary embolism. 这项对544名患者的研究发现,主要临床事件如死亡和复发在7天内减少了61%. The study of 544 patients found a 61% reduction in major clinical events like death and recurrence within seven days. 微创系统使用低剂量凝块溶解药物与超声波能量相结合,没有报告增加脑出血风险. The minimally invasive system uses low-dose clot-dissolving medication combined with ultrasound energy, with no increase in brain bleeding risk reported.